《强生Johnson &ampamp Johnson（JNJ）2024年第一季度业绩报告「NYSE」（英文版）（20页）.pdf》由会员分享，可在线阅读，更多相关《强生Johnson &ampamp Johnson（JNJ）2024年第一季度业绩报告「NYSE」（英文版）（20页）.pdf（20页珍藏版）》请在三个皮匠报告上搜索。

1、stApril 16,2024Cautionary note on Forward-looking statementsThis presentation contains“forward-looking statements”as defined in the Private Securities Litigation Reform Act of 1995 regarding,among other things:future operating and financial performance,product development,and market position and bus

2、iness strategy.The viewer is cautioned not to rely on these forward-looking statements.These statements are based on current expectations of future events.If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize,actual results could vary materially from the e

3、xpectations and projections of Johnson&Johnson.Risks and uncertainties include,but are not limited to:economic factors,such as interest rate and currency exchange rate fluctuations;competition,including technological advances,new products and patents attained by competitors;challenges inherent in ne

4、w product research and development,including uncertainty of clinical success and obtaining regulatory approvals;uncertainty of commercial success for new and existing products;challenges to patents;the impact of patent expirations;the ability of the Company to successfully execute strategic plans,in

5、cluding restructuring plans;the impact of business combinations and divestitures;manufacturing difficulties or delays,internally or within the supply chain;product efficacy or safety concerns resulting in product recalls or regulatory action;significant adverse litigation or government action,includ

6、ing related to product liability claims;changes to applicable laws and regulations,including tax laws and global health care reforms;trends toward health care cost containment;changes in behavior and spending patterns of purchasers of health care products and services;financial instability of intern